We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

58 hedge funds and large institutions have $71.6M invested in Abeona Therapeutics in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

28% more call options, than puts

Call options by funds: $132K | Put options by funds: $103K

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

7% more funds holding

Funds holding: 54 → 58 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.05% less ownership

Funds ownership: 1.49% → 1.43% (-0.05%)

1% less capital invested

Capital invested by funds: $72M → $71.6M (-$459K)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
15
Reduced
13
Closed
7
Calls
$132K
Puts
$103K
Net Calls
+$29K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
CHP
Castle Hook Partners
New York
+$1.88M
2
JGC
J. Goldman & Co
New York
+$1.47M
3
BlackRock
BlackRock
New York
+$1.33M
4
HCM
Highbridge Capital Management
New York
+$670K
5
Goldman Sachs
Goldman Sachs
New York
+$537K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$5.54M
2
PA
Perceptive Advisors
New York
-$1.13M
3
Jennison Associates
Jennison Associates
New York
-$686K
4
OM
Opaleye Management
Massachusetts
-$645K
5
CAM
Cormorant Asset Management
Massachusetts
-$516K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Laurion Capital Management
New York
$277K +$286K +2,216 New
Northern Trust
27
Northern Trust
Illinois
$254K +$35.9K +278 +16%
AAP
28
Ardsley Advisory Partners
Connecticut
$224K +$25.8K +200 +13%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$210K +$120K +934 +126%
SCM
30
Segantii Capital Management
Hong Kong
$169K +$149K +1,152 +565%
Tudor Investment Corp
31
Tudor Investment Corp
Connecticut
$168K – – –
HP
32
Hikari Power
Japan
$150K +$155K +1,200 New
Barclays
33
Barclays
United Kingdom
$131K +$134K +1,040 New
IA
34
IFP Advisors
Florida
$125K – – –
FM
35
Family Management
New York
$120K +$124K +960 New
PAG
36
Private Advisor Group
New Jersey
$108K +$36.1K +280 +50%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$103K -$12.4K -96 -10%
HFM
38
Hartford Financial Management
Connecticut
$89K +$41.8K +324 +83%
RIL
39
Rothschild Investment LLC
Illinois
$80K -$7.74K -60 -9%
Group One Trading
40
Group One Trading
Illinois
$69K -$15.9K -123 -18%
GP
41
GLG Partners
United Kingdom
$62K -$133K -1,035 -68%
Invesco
42
Invesco
Georgia
$62K +$64.1K +497 New
CG
43
Cutler Group
California
$44K +$45.9K +356 New
WP
44
WealthPLAN Partners
Nebraska
$23.9K +$24K +186 New
PCM
45
Prelude Capital Management
New York
$23K -$2.58K -20 -10%
Creative Planning
46
Creative Planning
Kansas
$11K – – –
GT
47
Glenmede Trust
Pennsylvania
$10K +$10.3K +80 New
Wells Fargo
48
Wells Fargo
California
$8K +$7.74K +60 New
LTFS
49
Ladenburg Thalmann Financial Services
Florida
$5K – – –
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$5K +$5.16K +40 New
1
2
3

ABEO Hedge Fund Activity: Q1 2017 in Review

58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2017, worth a combined $71.6M — down 0.64% from $72M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ABEO positions and 7 closed out — a net gain of 7 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Castle Hook Partners, adding an estimated $1.88M. The largest seller was RA Capital Management, exiting entirely with an estimated $5.54M sold.

  • 58 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2017, up from 54 in Q4 2016.
  • Funds reported $71.6M of Abeona Therapeutics stock for Q1 2017, down 0.64% quarter-over-quarter.
  • 14 funds opened new Abeona Therapeutics positions in Q1 2017 and 7 closed out, a net change of +7 holders.
  • The largest Abeona Therapeutics buyer in Q1 2017 was Castle Hook Partners, an estimated $1.88M added.
  • The largest Abeona Therapeutics seller in Q1 2017 was RA Capital Management, an estimated $5.54M sold.

Based on aggregated 13F filings for Q1 2017.